RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Genentech Inc.

A collection of news and information related to Genentech Inc. published by this site and its partners.

Top Genentech Inc. Articles see all

Displaying items 1-5
  • Asthma drug calms chronic hives, rashes

    Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found.
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

    Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Roche to buy U.S. biotech firm InterMune for $8.3 billion
    Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc. for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases. Roche's efforts to produce successful non-...

    Roche comprará firma de biotecnología EEUU por 8.300 mlns dlrs

    LONDRES/ZURICH (Reuters) - Roche Holding AG acordó comprar la compañía estadounidense de biotecnología InterMune por 8.300 millones de dólares en efectivo, en la última adquisición multimillonaria de un sector farmacéutico que apuesta cada vez más a la...

    'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...